UnknownNot Applicable

Association of Beta-Blocker Therapy at Discharge With Clinical Outcomes in Patients With Actue Coronary Syndrome

China582 participantsStarted 2018-03-02

Plain-language summary

Limited data are available on the efficacy of beta-blocker therapy for secondary prevention in Actue Coronary Syndrome(ACS) patients. This study sought to investigate the association of beta-blocker therapy at discharge with clinical outcomes in patients with ACS after percutaneous coronary intervention (PCI).

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. consecutive patients 18 years of age or older;
✓. patients diagnosed as ACS(including STEMI、NSTEMI and UA) by doctor at discharge;
✓. patients undergoing primary PCI.

What they're measuring

all-cause death

Timeframe: 3 years

Trial details

NCT IDNCT03658577

SponsorShenzhen People's Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2019-08

Contact for this trial

Feng Lin, MD

+8613510730251 119538892@qq.com

View on ClinicalTrials.gov More Actue Coronary Syndrome trials